A novel autoantibody signatures for enhanced clinical diagnosis of pancreatic ductal adenocarcinoma

A novel autoantibody signatures for enhanced clinical diagnosis of pancreatic ductal adenocarcinoma

Abstract Background Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease that requires precise diagnosis for effective treatment. However, the diagnostic value of carbohydrate antigen 19 − 9 (CA19-9) is limited. Therefore, this study aims to identify novel tumor-associated autoantibodies...

Full description

Bibliographic Details
Main Authors: Tiandong Li, Junfen Xia, Huan Yun, Guiying Sun, Yajing Shen, Peng Wang, Jianxiang Shi, Keyan Wang, Hongwei Yang, Hua Ye
Format: Article
Language:English
Published: BMC 2023-11-01
Series:Cancer Cell International
Subjects:
Pancreatic ductal adenocarcinoma
Autoantibody
Diagnosis
Immunodiagnostic
Model
Online Access:https://doi.org/10.1186/s12935-023-03107-1

Internet

https://doi.org/10.1186/s12935-023-03107-1

Similar Items